Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery.

Source:http://linkedlifedata.com/resource/pubmed/id/20124177

J. Clin. Oncol. 2010 Mar 1 28 7 1196-202

Download in:

View as

General Info

PMID
20124177